Loading data
SCKTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 15.08 m USD | 18.76 m USD | 17.03 m USD | 21.24 m USD | 23.2 m USD |
| Cost of revenue | 7.59 m USD | 9.31 m USD | 8.57 m USD | 10.87 m USD | 10.76 m USD |
| Gross profit | 7.49 m USD | 9.45 m USD | 8.46 m USD | 10.37 m USD | 12.44 m USD |
| Research and development expense | 4.35 m USD | 4.72 m USD | 4.83 m USD | 4.36 m USD | 3.96 m USD |
| Operating profit | -3.22 m USD | -2.46 m USD | -3.12 m USD | -446.02 k USD | 2.7 m USD |
| Interest expense | -496.59 k USD | -330.85 k USD | -242.16 k USD | -175.05 k USD | 198.94 k USD |
| Income tax expense | -10.66 m USD | 551 k USD | 1.44 m USD | 708 k USD | 1.9 m USD |
| Net income (reported basis) | -14.38 m USD | -2.24 m USD | -1.92 m USD | 86.93 k USD | 4.47 m USD |
| Net income attributable to common shareholders | — | — | -1.92 m USD | 78.11 k USD | 4.09 m USD |
| Basic earnings per share | -1.81 USD/share | -0.3 USD/share | -0.27 USD/share | 0.01 USD/share | 0.58 USD/share |
| Diluted earnings per share | -1.81 USD/share | -0.3 USD/share | -0.27 USD/share | 0.01 USD/share | 0.48 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.